top of page
Writer's pictureMayta

Pathophysiology of Shivering After FFP Transfusion and How to management

A table detailing the management of patients experiencing shivering after FFP transfusion based on whether they can eat (NPO status) or not:

Condition

Management of Patient Can Eat

Management of Patient is NPO

Shivering



Immune Response



Allergic Reaction

- Cetirizine (10 mg orally once daily)

- Cetirizine (10 mg IV if available, otherwise avoid)


- Loratadine (10 mg orally once daily)

- Loratadine (10 mg IV if available, otherwise avoid)


- Acetaminophen (500-1000 mg orally every 6 hours)

- Acetaminophen (500-1000 mg IV every 6 hours)


- Hydration with oral fluids

- IV fluids to maintain hydration

Non-Immune



Hypothermia

- Warm oral fluids

- Warm IV fluids


- Warm blankets

- Warm blankets




Febrile Non-Hemolytic Transfusion Reaction (FNHTR)




- Acetaminophen (500-1000 mg orally every 6 hours)

- Acetaminophen (500-1000 mg IV every 6 hours)


- Hydration with oral fluids

- IV fluids to maintain hydration


- Monitor temperature

- Monitor temperature

Severe Allergic Reactions/Inflammatory Responses



CPM

- Chlorpheniramine (4 mg orally every 6-8 hours)

- Chlorpheniramine (10-20 mg IV every 6-12 hours)


- Hydrocortisone (if needed, 20 mg orally)

- Hydrocortisone (100 mg IV bolus)


- Methylprednisolone (if needed, 4 mg orally)

- Methylprednisolone (40-125 mg IV)




General Measures




- Monitor vital signs

- Monitor vital signs


- Educate patient about possible reactions

- Educate patient about possible reactions


- Encourage rest

- Ensure patient comfort and rest

Introduction Shivering after the transfusion of Fresh Frozen Plasma (FFP) is a clinical symptom that can cause discomfort and indicate an adverse reaction to the transfusion. Understanding the pathophysiology behind this reaction is crucial for effective management and treatment. This article explores the mechanisms leading to shivering post-FFP transfusion and outlines the appropriate medical interventions and dosages for treating this symptom.

Pathophysiology of Shivering Post-FFP Transfusion

  • Immune Response to Transfused Plasma

    • Allergic Reactions: Shivering can result from an allergic reaction to plasma proteins in the transfused FFP. This reaction is typically mild but can trigger the release of histamines and other inflammatory mediators.

    • Cytokine Release: The introduction of donor plasma can activate immune cells, leading to the release of cytokines such as interleukins and tumor necrosis factor (TNF), which can induce shivering.

  • Non-Immune Mechanisms

    • Hypothermia: FFP is usually stored at very low temperatures and can cause a drop in body temperature when transfused rapidly. This hypothermic effect can directly induce shivering as the body attempts to generate heat.

    • Metabolic Effects: Rapid infusion of cold FFP can affect the body's metabolic rate and thermoregulation processes, contributing to shivering.

  • Acute Transfusion Reactions

    • Febrile Non-Hemolytic Transfusion Reaction (FNHTR): This common type of reaction occurs due to the presence of donor leukocytes and cytokines in the FFP. It is characterized by fever and chills, including shivering.

    • Transfusion-Related Acute Lung Injury (TRALI): Although rare, TRALI is a serious reaction that can present with symptoms including shivering, due to immune-mediated damage to the lungs.

Assessment and Management

When managing shivering after FFP transfusion, it's crucial to first assess the patient for any signs of anaphylaxis, which includes:

  • Skin: Check for maculopapular rash (MP rash), urticaria, or angioedema.

  • Respiratory: Listen for wheezing, stridor, or difficulty breathing.

  • Cardiovascular: Monitor for hypotension or tachycardia.

  • Gastrointestinal: Look for symptoms like nausea, vomiting, or abdominal pain.

Based on whether the patient can eat (is not NPO) or is NPO, the approach to management varies.

  • If the Patient Can Eat

    • Acetaminophen (Paracetamol)

      • Indication: Used to reduce fever and alleviate discomfort associated with shivering.

      • Dosage: 500-1000 mg orally every 6 hours as needed (maximum 4,000 mg in 24 hours).

    • Cetirizine or Loratadine

    • Indication: Used to counteract mild allergic reactions causing shivering.

    • Dosage: Cetirizine 10 mg orally once daily or Loratadine 10 mg orally once daily.

    • Hydration and Warmth

      • Provide warm oral fluids and cover the patient with warm blankets to counteract hypothermia.

  • If the Patient is NPO

    • Acetaminophen (Paracetamol)

      • Indication: Used to reduce fever and alleviate discomfort associated with shivering.

      • Dosage: 500-1000 mg IV every 6 hours as needed (maximum 4,000 mg in 24 hours).

    • Chlorpheniramine (CPM)

      • Indication: Used to counteract mild allergic reactions causing shivering.

      • Dosage: 10-20 mg intravenously every 6-12 hours as needed.

    • Hydrocortisone

      • Indication: Used for severe allergic reactions or in cases of persistent shivering not responding to antihistamines.

      • Dosage: 100 mg IV bolus in emergency situations.

    • Methylprednisolone (Solu-Medrol)

      • Indication: Used for severe inflammatory or allergic reactions.

      • Dosage: 40-125 mg IV, based on the severity of symptoms.

    • Hydration and Warmth

      • Provide warm IV fluids and cover the patient with warm blankets to counteract hypothermia.

Important Note: Always perform a thorough physical examination to rule out anaphylaxis, which includes checking for MP rash, wheezing, hypotension, and other signs of severe allergic reactions. Immediate intervention is required if any signs of anaphylaxis are detected.

Conclusion

Shivering after FFP transfusion is a multifactorial symptom that can arise from immune and non-immune mechanisms. Proper management involves identifying the underlying cause and administering appropriate medications to alleviate the symptoms. Understanding the pathophysiology of shivering and the pharmacological interventions available ensures effective treatment and improves patient comfort and safety during transfusions. Always consult with a healthcare provider for tailored medical advice and treatment plans.

Recent Posts

See All

Ischemic stroke keeps BP?

For ischemic stroke, AHA/ASA guidelines recommend keeping BP < 185/110 mmHg with IV t-PA, and allowing BP < 220/120 mmHg without t-PA....

ระบบบริการปฐมภูมิ (Primary Health Care) ในประเทศไทย

ระบบบริการปฐมภูมิถือเป็นรากฐานสำคัญของระบบสาธารณสุขในประเทศไทย มีบทบาทในการดูแลสุขภาพขั้นต้นให้แก่ประชาชน โดยเฉพาะในพื้นที่ชนบทและชุมชนห่...

คุณลักษณะและการจัดระบบบริการปฐมภูมิในประเทศไทย

การบริการปฐมภูมิ (Primary Health Care) มีบทบาทสำคัญในระบบสาธารณสุข เนื่องจากเป็นจุดแรกที่ประชาชนสามารถเข้าถึงการดูแลสุขภาพได้อย่างเหมาะสม...

Comments

Rated 0 out of 5 stars.
No ratings yet

Add a rating
Post: Blog2_Post
bottom of page